Zhong, Jim http://orcid.org/0000-0001-5325-3739
Frood, Russell
McWilliam, Alan
Davey, Angela
Shortall, Jane
Swinton, Martin
Hulson, Oliver
West, Catharine M.
Buckley, David
Brown, Sarah
Choudhury, Ananya
Hoskin, Peter
Henry, Ann
Scarsbrook, Andrew
Funding for this research was provided by:
Cancer Research UK (95653117/95653118, CTRQQR-2021\100010, RadNet C19942/A28832, RadNet C19942/A28832, CTRQQR-2021\100010)
Manchester Biomedical Research Centre
Article History
Received: 15 March 2023
Accepted: 26 April 2023
First Online: 17 May 2023
Declarations
:
: The authors have no relevant financial or non-financial interests to disclose.
: Informed consent was obtained from all individual participants included in the study.
: This study was performed in line with the principles of the Declaration of Helsinki. The study was approved by the United Kingdom North West Research Ethics Committee (Validation and qualification of a multiplex hypoxia biomarker for radiotherapy individualisation in prostate cancer study (IRAS 15/NW/0559)).